IDBS continues to drive expansion with key appointments

Guildford, UK, and Boston, MA, 

For Immediate Release

IDBS, a leader in enterprise scientific informatics platforms, today announced the appointments of Graeme Dennis as Pre-Clinical Pharma Commercial Director, Abhay Kini as Director of Product Management and April Pisek as Solutions Consultant. These appointments strengthen IDBS’ ability to lead the way in helping R&D organizations create labs of the future, as well as their preclinical footprint in the scientific informatics market, furthering its position as one of the leading global providers of data management solutions and services to preclinical and bioanalytical organizations.


Graeme Dennis will be responsible for driving IDBS’ expansion in scientific informatics strategy, implementation and integration Graeme has a 15-year track record in pre-clinical pharma and discovery informatics, holding senior roles at Accenture’s LabAnswer, Dotmatics, Vanderbilt University Medical Center and Harvard University. He has a Bachelor of Science degree in Chemistry from Vanderbilt University and is based in Boston, MA.

Abhay Kini will help deliver IDBS’ vision of a digital lab, driving product marketing, management and strategy. Abhay’s career spans over 15 years in R&D and consulting services in life sciences, holding positions at Waters Corporation, Medidata Solutions and Oracle.  He has a PhD in Chemistry from Purdue University in West Lafayette, Indiana and pursued post-doctoral research in the molecular bases of olfaction at Columbia University.

April Pisek brings a decade of expertise in quantitative bioanalysis and drug development support for small biotech and large pharma companies. Prior to joining IDBS, April worked at AIT Bioscience where she held a succession of positions including ELN Administrator, building templates ranging from sample prep to anti-drug antibody. She has a Bachelor of Science degree in Chemistry from Ball Start University and is based in Indianapolis, Indiana.

These appointments follow the earlier announcement of Christian Marcazzo, General Manager at IDBS.

Christian Marcazzo said: “Attracting talent like Graeme, Abhay and April underlines the importance of bringing scientific talent to our product and go-to-market strategy. These appointments bring us deep domain expertise and a fundamental understanding of how technology helps our customers discover and develop new therapeutics.”

Graeme Dennis, Pre-Clinical Pharma Commercial Director at IDBS, said: “I'm excited to join IDBS – its application of digital technologies that transform scientific and laboratory processes has set the standard in scientific informatics solutions. I look forward to adding to this achievement as we continue to develop commercial applications over the coming years.”

Abhay Kini, Director of Product Management at IDBS, said: “I am very pleased to have the opportunity to join IDBS. I look forward to bringing my experience and skills to a team that is committed to delivering the highest levels of customer satisfaction across all aspects of the business.”

April Pisek, Solutions Consultant at IDBS, said: “When it comes to supporting drug development, IDBS’ technology and its commitment to delivering a high-quality service that is defined from the customer’s point of view is a big reason why I joined the company. I am delighted to be part of the team that delivers this innovation, ensuring IDBS continues its growth trajectory.”

Graeme and Abhay will report to Scott Weiss, Vice President, Product Strategy and April will report to Rehan Malik, Head of Strategic Business Consulting Services.

-- Ends –


For media enquiries, please contact:

Orsolya Fekete

Metia Group

+44 203 100 3564

About IDBS:

IDBS is a leading global provider of innovative enterprise data management, analytics and modeling solutions. The company’s uniquely sophisticated platform technologies are used by more than 200 pharmaceutical companies, major healthcare providers, global leaders in academic study, and high-tech companies around the world, to increase efficiency, reduce costs and improve the productivity of industrial R&D and clinical research. IDBS is clearly differentiated by its unique combination of award-winning enterprise technologies and domain knowledge in R&D.

IDBS’ solutions help scientists, hospitals and R&D businesses produce the world’s newest therapeutics, diagnostics and personalized treatments; faster, cleaner engines and fuels; breakthroughs in productive agriculture; healthier, safer food products; high-tech materials and consumer products.

Founded in 1989, IDBS is headquartered in Guildford, UK with a direct sales and support presence worldwide. IDBS is a Profit Track 100 company and the recipient of multiple awards including the Frost and Sullivan ‘Enabling Technology’ Award in R&D data management for 2010 and Queen’s Award for International Trade 2011. Further information can be found at, or follow us on Twitter @IDBSsoftware.

Back to news